| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/02/2013 | US20130109568 Compositions and Methods for Therapeutic Delivery with Microorganisms |
| 05/02/2013 | US20130109098 Biosecure genetically modified algae |
| 05/02/2013 | US20130109097 Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes |
| 05/02/2013 | US20130109096 Method for gene transfer |
| 05/02/2013 | US20130109095 Method for transfecting a eukaryotic cell |
| 05/02/2013 | US20130109091 Compositions and methods for modulation of smn2 splicing |
| 05/02/2013 | US20130109090 Methods for reprogramming somatic cells |
| 05/02/2013 | US20130109089 Methods for reprogramming somatic cells |
| 05/02/2013 | US20130109070 Transformant for enhancing bioethanol production, and method for producing ethanol by using said strain |
| 05/02/2013 | US20130109069 Microorganisms for the production of 1,4-butanediol |
| 05/02/2013 | US20130109067 Method for the preparation of hydroxy acids |
| 05/02/2013 | US20130109064 Microorganisms and methods for producing 2,4-pentadienoate, butadiene, propylene, 1,3-butanediol and related alcohols |
| 05/02/2013 | US20130109063 Method for Producing an L-Amino Acid Using a Bacterium of the Enterobacteriaceae Family |
| 05/02/2013 | US20130109061 Hyperproliferative recombinant cell |
| 05/02/2013 | US20130109058 Polypeptide producing cells |
| 05/02/2013 | US20130109055 Use of mammalian promoters in filamentous fungi |
| 05/02/2013 | US20130109054 Use of plant promoters in filamentous fungi |
| 05/02/2013 | US20130109013 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith |
| 05/02/2013 | US20130108771 Lettuce variety 79-25 rz |
| 05/02/2013 | US20130108704 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 05/02/2013 | US20130108687 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders |
| 05/02/2013 | US20130108650 Actriib binding agents and uses thereof |
| 05/02/2013 | US20130108620 Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 05/02/2013 | US20130108584 Recombinant vector for producing and secreting amino acid sequences of interest by propionibacteria and applications thereof |
| 05/02/2013 | US20130108578 Apo-2 ligand variants and uses thereof |
| 05/02/2013 | US20130108546 Humanized Antibodies That Recognize Alpha-Synuclein |
| 05/02/2013 | DE102011118021A1 Leistungsverbesserte und temperaturstabile Proteasevarianten Performance enhanced and temperature-stable protease variants |
| 05/02/2013 | CA2853609A1 Inhibition of viral gene expression |
| 05/02/2013 | CA2853531A1 Humanized antibodies that recognize alpha-synuclein |
| 05/02/2013 | CA2853522A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
| 05/02/2013 | CA2853449A1 Methods to alter plant cell wall composition for improved biofuel production and silage digestibility |
| 05/02/2013 | CA2853379A1 Vectors encoding rod-derived cone viability factor |
| 05/02/2013 | CA2853377A1 Methods and compositions for assessing patients with reproductive failure using immune cell-derived microrna |
| 05/02/2013 | CA2853373A1 Antisense modulation of gccr expression |
| 05/02/2013 | CA2853341A1 Engineered lower eukaryotic host strains for recombinant protein expression |
| 05/02/2013 | CA2853338A1 Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression |
| 05/02/2013 | CA2853125A1 Isoprene synthase variants with improved solubility for production of isoprene |
| 05/02/2013 | CA2853112A1 Antibody formulations and methods |
| 05/02/2013 | CA2853023A1 Geminivirus replication inhibitor |
| 05/02/2013 | CA2852955A1 Methods and compositions for modification of the hprt locus |
| 05/02/2013 | CA2852633A1 Topk peptides and vaccines including the same |
| 05/02/2013 | CA2852631A1 A gene and mutations thereof associated with seizure and movement disorders |
| 05/02/2013 | CA2852629A1 Usp2a peptides and antibodies |
| 05/02/2013 | CA2851336A1 Improved hcv vaccines and methods for using the same |
| 05/02/2013 | CA2850390A1 Methods and compositions for silencing genes using artificial micrornas |
| 05/02/2013 | CA2850328A1 Transcription unit and use thereof in (yb2/0) expression vectors |
| 05/02/2013 | CA2850295A1 Method for preparing human factor h |
| 05/02/2013 | CA2849241A1 Construct |
| 05/01/2013 | EP2586867A1 Transient expression lentiviral vectors, preparation and uses thereof |
| 05/01/2013 | EP2586866A1 A method for sustainable transgene transcription |
| 05/01/2013 | EP2586865A2 Recombinant vector for suppressing proliferation of human papillomavirus cell including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papillomavirus |
| 05/01/2013 | EP2586864A1 Upregulating of miR-15b for preventing cellular senescence and tissue aging |
| 05/01/2013 | EP2586863A1 High-speed maturation method for an oligonucleotide library for the purpose of preparing a protein library |
| 05/01/2013 | EP2586862A1 Detection method for novel ros1 fusion product |
| 05/01/2013 | EP2586861A1 Composition for preventing evaporation of reaction solution during nucleic acid amplification reaction |
| 05/01/2013 | EP2586860A1 Novel glycosyl hydrolase with beta-xylosidase and beta-glucosidase activities and uses thereof |
| 05/01/2013 | EP2586798A2 B-cell reduction using CD37-specific and CD20-specific binding molecules |
| 05/01/2013 | EP2586796A1 Compositions and methods for use for antibodies against sclerostin |
| 05/01/2013 | EP2586792A1 Modulating beta-damascenone in plants |
| 05/01/2013 | EP2586462A1 Prophylactic or ameliorating agent for genetic diseases |
| 05/01/2013 | EP2586313A1 Fermentation process using yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol |
| 05/01/2013 | EP2586294A1 Peronospora resistance in Spinacia oleracea |
| 05/01/2013 | EP2585604A1 Plants having enhanced yield-related traits and method for making the same |
| 05/01/2013 | EP2585603A1 Acyltransferases and uses therof in fatty acid production |
| 05/01/2013 | EP2585602A1 Polynucleotides having promoter activity |
| 05/01/2013 | EP2585601A1 Polynucleotides having promoter activity |
| 05/01/2013 | EP2585600A2 Lowering saturated fatty acid content of plant seeds |
| 05/01/2013 | EP2585599A2 Accumulation of omega-7 fatty acids in plant seeds |
| 05/01/2013 | EP2585598A2 Pan-lyssavirus vaccines against rabies |
| 05/01/2013 | EP2585597A1 Plants with enhanced yield-related traits and producing method thereof |
| 05/01/2013 | EP2585596A2 Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna |
| 05/01/2013 | EP2585595A2 Rna molecules and uses thereof |
| 05/01/2013 | EP2585594A1 Double stranded rna compounds to rhoa and use thereof |
| 05/01/2013 | EP2585593A2 Methods and compositions for polynucleotide library production, immortalization and region of interest extraction |
| 05/01/2013 | EP2585592A2 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
| 05/01/2013 | EP2585591A1 Polynucleotides having leader sequence function |
| 05/01/2013 | EP2585589A1 Methods of producing lipids |
| 05/01/2013 | EP2585487A2 Coincidence detection |
| 05/01/2013 | EP2585478A1 Plant eukaryotic translation initiation factor 4e |
| 05/01/2013 | EP2585115A2 Cancer therapy |
| 05/01/2013 | EP2585089A1 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 05/01/2013 | EP2584887A1 Compositions and methods for enhancing resistance to northern leaf blight in maize |
| 05/01/2013 | EP2584886A1 Methods for agrobacterium-mediated transformation of sugar cane |
| 05/01/2013 | CN1662556B Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 05/01/2013 | CN103080334A Micro-RNA biomarkers and methods for diagnosis of early colorectal carcinoma and high-grade adenoma |
| 05/01/2013 | CN103080326A Recombinant bacteria for producing glycerol and glycerol-derived products from sucrose |
| 05/01/2013 | CN103080323A Linear DNA molecule delivery using pegylated quantum dots for stable transformation in plants |
| 05/01/2013 | CN103080322A Semi-stable production of lentiviral vectors |
| 05/01/2013 | CN103080321A DNA element having the activity of enhancing foreign gene expression |
| 05/01/2013 | CN103080320A Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding PAE and PAE-like polypeptides |
| 05/01/2013 | CN103080319A Production of DHA and other LC-PUFAs in plants |
| 05/01/2013 | CN103080318A Bacterial surface display and screening of thioether-bridge-containing peptides |
| 05/01/2013 | CN103080317A Mutant HPGG motif and HDASH motif delta-5 desaturases and their use in making polyunsaturated fatty acids |
| 05/01/2013 | CN103080316A Mutant delta-9 elongases and their use in making polyunsaturated fatty acids |
| 05/01/2013 | CN103080315A UDP-glucose-4-epimerase useful for improving agronomic performance of plants |
| 05/01/2013 | CN103080314A Inhibitor of expression of dominantly mutated gene |
| 05/01/2013 | CN103080313A Conjugates, particles, compositions, and related methods |
| 05/01/2013 | CN103080312A Primer pairs for detecting orientia tsutsugamushi and detection method using the same |
| 05/01/2013 | CN103080311A Method of isolating purified RNA with reduced DNA contaminations |
| 05/01/2013 | CN103080310A Method for inhibiting nucleic acid amplification using light and highly sensitive method for selective nucleic acid amplification |